Clinical trial
Prospective Observational Cohort Study of Patients With Moderate to Severe Chronic Plaque Psoriasis in Taiwan
NCT04818385 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observational Cohort Study of Patients With Moderate to Severe Chronic Plaque Psoriasis in Taiwan
- Lead sponsor
- AbbVie
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2021
- Completion date
- August 1, 2025
- Enrollment
- 240 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.